GSA Capital Partners’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Buy	+45,073	New	+$1.48M	0.08%	360
2025 Q2	–	Sell	-20,722	Closed	-$688K	–	1912
2025 Q1	$688K	Buy	+20,722	New	+$743K	0.06%	577
2024 Q4	–	Sell	-5,873	Closed	-$235K	–	1776
2024 Q3	$235K	Buy	+5,873	New	+$206K	0.02%	1348
2023 Q4	–	Sell	-12,898	Closed	-$423K	–	1681
2023 Q3	$423K	Buy	12,898 +6,287	+95%	+$218K	0.04%	895
2023 Q2	$233K	Sell	6,611 -42,151	-86%	-$1.46M	0.02%	1184
2023 Q1	$1.59M	Buy	48,762 +19,618	+67%	+$893K	0.16%	124
2022 Q4	$1.61M	Buy	29,144 +8,292	+40%	+$456K	0.2%	52
2022 Q3	$924K	Buy	20,852 +16,045	+334%	+$783K	0.12%	193
2022 Q2	$234K	Sell	4,807 -1,793	-27%	-$80.7K	0.04%	975
2022 Q1	$321K	Buy	6,600 +1,563	+31%	+$63.7K	0.04%	846
2021 Q4	$215K	Buy	+5,037	New	+$201K	0.03%	1161